Atrial fibrillation (AF) is the most common arrhythmia. It is expected to affect 6-12 million Americans by 2050. AF is a major public health burden, associated with a 5-fold increased stroke risk, doubling in dementia risk, tripling in heart failur risk and nearly 2-fold increase in mortality. The estimated excess cost of health care due to AF is nearly $26 billion annually. AF is known to be heritable, and in recent years, 3 genetic loci fo AF have been identified through genome-wide association studies. More recently, we completed a large meta-analysis of genome-wide studies and identified 6 novel loci for AF. We will build upon our prior work using a multidisciplinary approach that integrates targeted sequencing of all 9 AF GWAS loci, robust replication in the CHARGE AF Consortium, and model system based functional analyses. We will take advantage of two well- characterized cohorts with early-onset AF from the Framingham Heart Study and Massachusetts General Hospital. Specifically, we propose to: 1) Identify potentially causative genetic variants at the 9 published GWAS loci by analyzing extant targeted sequencing data of the top 5 loci for AF generated by the NIH Resequencing and Genotyping Service in 480 individuals with early-onset AF and 480 referents and by performing new targeted sequencing of 4 additional AF loci in the same subjects. 2) Replicate the top 400 AF variants with MAF>0.5% identified in our targeted sequencing projects in 5,776 independent AF cases and 9,229 referents, and replicate the rare and singleton SNPs (MAF<0.5%) in the top 3 genetic regions in 1,000 independent individuals with early-onset AF and 1,000 referents. 3) Functionally evaluate the newly identified genetic variants for AF by using cellular electrophysiology to characterize coding variation in ion channel and using a combination of zebra fish, mice, and cell-based assays to examine non-coding variants at the two most promising AF related loci. Our translational approach will facilitate a greater understanding of the molecular basis of this common and morbid arrhythmia. Identification of causative variants may enhance risk stratification, and will provide preventive and therapeutic targets for drug discovery in the broader scientific and pharmaceutical community.

Public Health Relevance

Despite affecting ~3 million Americans, relatively little is known about the underlying mechanisms that lead to atrial fibrillation (AF). The goal of this application is to perform sequencing of 9 genomic regions associated with AF in individuals with early-onset atrial fibrillation to find the causative genetic variants associated with this arrhythmia. Identifying the causal variants will lead to better risk stratification, improved treatment, and potentially prevention of AF.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL092577-06
Application #
8652323
Study Section
Cardiovascular and Sleep Epidemiology Study Section (CASE)
Program Officer
Papanicolaou, George
Project Start
2008-04-01
Project End
2018-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Martins, Maria Auxiliadora Parreiras; Costa, Josiane Moreira; Mambrini, Juliana Vaz de Melo et al. (2017) Health literacy and warfarin therapy at two anticoagulation clinics in Brazil. Heart 103:1089-1095
Christophersen, Ingrid E; Magnani, Jared W; Yin, Xiaoyan et al. (2017) Fifteen Genetic Loci Associated With the Electrocardiographic P Wave. Circ Cardiovasc Genet 10:
Staerk, Laila; Sherer, Jason A; Ko, Darae et al. (2017) Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res 120:1501-1517
Lubitz, Steven A; Yin, Xiaoyan; McManus, David D et al. (2017) Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study. Stroke 48:490-492
Russo, Abigail R; Solis, Amy C; Villanti, Andrea C et al. (2017) Mentoring for Success in Tobacco Regulatory Science: A Qualitative Study. Tob Regul Sci 3:280-292
Christophersen, Ingrid E; Rienstra, Michiel; Roselli, Carolina et al. (2017) Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet 49:946-952
Rosenberg, Michael A; Lubitz, Steven A; Lin, Honghuang et al. (2017) Validation of Polygenic Scores for QT Interval in Clinical Populations. Circ Cardiovasc Genet 10:
Ma, Jiantao; Hwang, Shih-Jen; Pedley, Alison et al. (2017) Bi-directional analysis between fatty liver and cardiovascular disease risk factors. J Hepatol 66:390-397
Heckbert, Susan R; Wiggins, Kerri L; Blackshear, Chad et al. (2017) Pericardial fat volume and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis and Jackson Heart Study. Obesity (Silver Spring) 25:1115-1121
Tucker, Nathan R; Dolmatova, Elena V; Lin, Honghuang et al. (2017) Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential. Circ Cardiovasc Genet 10:

Showing the most recent 10 out of 184 publications